<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72262">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02002442</url>
  </required_header>
  <id_info>
    <org_study_id>10951</org_study_id>
    <nct_id>NCT02002442</nct_id>
  </id_info>
  <brief_title>Dental Implants and Mouth Rinse</brief_title>
  <official_title>Comparison of the Effect of the Preoperative Use of Chlorhexidine, Essential Oil, and Cetylpyridinium Chloride Mouthwashes on Bacterial Contamination During Dental Implant Placement: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University School of Dental Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tufts University School of Dental Medicine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to evaluate and compare the efficacy of a 60 second rinse
      with chlorhexidine, essential oil-based mouthwash, cetylpyridinium chloride mouthwash, or
      saline solution on bacterial contamination in the buccal vestibule when used preoperatively
      using the real-time Polymerase Chain Reaction (qPCR).

      We hypothesize that preoperative rinse with chlorhexidine mouthwash will result in greater
      reduction of bacterial counts than with essential oil-based, cetylpyridinium chloride, or
      saline mouthwashes.

      The secondary aim of this study is to evaluate the effect of the tested mouthwashes in
      reducing the bacterial counts over time.

      We hypothesize that preoperative rinse with chlorhexidine mouthwash will result in a
      reduction of bacterial counts for longer duration than with essential oil-based,
      cetylpyridinium chloride, or saline mouthwashes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Oral Rinse Comparison</measure>
    <time_frame>60 seconds rinse</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary aim of this study is to evaluate and compare the efficacy of a 60 second rinse with chlorhexidine, essential oil-based mouthwash, cetylpyridinium chloride mouthwash, or saline solution on bacterial contamination in the buccal vestibule when used preoperatively using the real-time Polymerase Chain Reaction (qPCR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacterial Count Reduction</measure>
    <time_frame>60 seconds rinse</time_frame>
    <safety_issue>No</safety_issue>
    <description>The secondary aim of this study is to evaluate the effect of the tested mouthwashes in reducing the bacterial counts over time.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Reduction in Bacterial Counts Through the Use of Mouthwash</condition>
  <arm_group>
    <arm_group_label>0.12% Chlorhexidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Alcohol-free Chlorhexidine Gluconate Oral Rinse USP, 0.12% from GUM®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Essential oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>LISTERINE® ZERO™ Mouthwash</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.07% Cetylpyridinium Chloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Crest Pro-Health Multi-Protection Rinse - Refreshing Clean Mint (Procter and Gamble)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mouthwash</intervention_name>
    <description>An investigator will give the patient the assigned mouthwash based on the randomized group allocation. 30ml of the mouthwash will be given to the subject in a sterilized calibrated tube.  The subject will be asked to rinse for 60 seconds. Then, the patient will spit the mouthwash.</description>
    <arm_group_label>0.12% Chlorhexidine</arm_group_label>
    <arm_group_label>Essential oil</arm_group_label>
    <arm_group_label>0.07% Cetylpyridinium Chloride</arm_group_label>
    <arm_group_label>Saline</arm_group_label>
    <other_name>0.12% Chlorhexidine</other_name>
    <other_name>Essential oil</other_name>
    <other_name>0.07% Cetylpyridinium Chloride</other_name>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who is treatment planned for dental implant placement and qualifies for
             dental implant placement according to the standards of care in the Department of
             Periodontology at Tufts University School of Dental Medicine.

          -  Aged 18 years and above.

          -  Partially edentulous.

        Exclusion Criteria:

          -  Antibiotic therapy within 2 weeks of the study.

          -  Active infection in the oral cavity.

          -  Known allergy to any of the agents used in the study.

          -  Self-reported pregnancy (as the surgical procedure of dental implant placement is
             elective and typically deferred until after the delivery).

          -  Fully edentulous.

          -  Patient with severe periodontitis (Clinical attachment loss of 5mm or more in the
             majority of intraoral sites).

          -  Regular use of mouthwashes (once/day).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tufts University School of Dental Medicine Department of Periodontology</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Hur, DMD, MS</last_name>
      <phone>617-636-3887</phone>
      <email>yong.hur@tufts.edu</email>
    </contact>
    <contact_backup>
      <last_name>Wael Yaghmoor, BDS</last_name>
      <phone>781-605-7852</phone>
      <email>wael.yaghmoor@tufts.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Yong Hur, DMD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wael Yaghmoor, BDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yumi Ogata, DDs, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Hanley, DMD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 4, 2013</lastchanged_date>
  <firstreceived_date>November 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Moutwash</keyword>
  <keyword>Chlorhexidine</keyword>
  <keyword>cetylpyridinium chloride</keyword>
  <keyword>Saline</keyword>
  <keyword>Implants</keyword>
  <keyword>Saliva Collection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cetylpyridinium</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
